APELLIS PHARMACEUTICALS INC

CUSIP: 03753UAB2 Class: NOTE 3.500% 9/1

WOLVERINE ASSET MANAGEMENT LLC's Holding History (CIK: 0001279891)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 3,122,000 Value ($000) $3,224 Avg Close — Range —
Q3 2025
Shares 3,122,000 Value ($000) $3,197 Avg Close — Range —
Q2 2025
Shares 2,967,000 Value ($000) $2,957 Avg Close — Range —
Q1 2025
Shares 2,967,000 Value ($000) $3,080 Avg Close — Range —
Q4 2024
Shares 2,667,000 Value ($000) $3,089 Avg Close — Range —
Q4 2023
Shares 11,766,000 Value ($000) $19,221 Avg Close — Range —
Q3 2023
Shares 11,766,000 Value ($000) $14,864 Avg Close — Range —
Q2 2023
Shares 11,766,000 Value ($000) $28,207 Avg Close — Range —
Q1 2023
Shares 12,175,000 Value ($000) $22,670 Avg Close — Range —
Q4 2022
Shares 12,175,000 Value ($000) $18,703 Avg Close — Range —
Q3 2022
Shares 8,325,000 Value ($000) $16,256 Avg Close — Range —
Q2 2022
Shares 43,874,000 Value ($000) $65,016 Avg Close — Range —
Q1 2022
Shares 61,374,000 Value ($000) $97,046 Avg Close — Range —
Q4 2021
Shares 46,874,000 Value ($000) $70,903 Avg Close — Range —
Q3 2021
Shares 33,996,000 Value ($000) $41,869 Avg Close — Range —
Q2 2021
Shares 42,855,000 Value ($000) $79,763 Avg Close — Range —
Q1 2021
Shares 3,000,000 Value ($000) $4,206 Avg Close — Range —
Q4 2020
Shares 12,502,000 Value ($000) $20,991 Avg Close — Range —
Q3 2020
Shares 12,502,000 Value ($000) $13,594 Avg Close — Range —